Cancer
We’re investigating the biological basis of many solid and blood borne malignancies, advancing diagnosis, developing and trialing new therapies, and improving all aspects of the management of cancer including palliative care.
Do you have metastatic , HER2 negative breast cancer?
The purpose of this study is to evaluate the safety and effectiveness of gedatolisib at treating your cancer when combined with other cancer drugs, compared to the standard of care for people with breast cancer.
Do you have locally advanced or metastatic non-clear cell renal cell carcinoma?
The research project is testing a potential new treatment for nccRCC, called XL092 in a combination with nivolumab.
Do you have advanced ovarian, peritoneal or fallopian tube cancer?
A potential new treatment for advanced ovarian, peritoneal or fallopian tube cancer.
Do you have ovarian, peritoneal or fallopian tube cancer?
The purpose of this study is to test a potential new treatment for ovarian, peritoneal or fallopian tube cancer called ZN-c3-also known as azenosertib.
Testing the safety of a new imaging agent in patients with epithelial ovarian cancer.
The primary aim of this clinical trial is to test the safety of a new imaging agent in patients with epithelial ovarian cancer.